For many investors watching developments in the psychedelic space, it is a matter of when, not if, substances such as psilocybin will become widespread in the treatment of serious mental illness and addiction
Octarine Bio announces the expansion of its Scientific Advisory Board prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
The Newly Institute Announces the Execution of a Joint Working Agreement with Drug Science for the Drug Science Medical Psychedelics Working Group finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Share:
Professor Jo Neill and Parminder Singh bring psychopharmacology and IP protection & licensing expertise to a company pursuing psilocybin-based therapies
VANCOUVER, BC, May 25, 2021 /CNW/ - Albert Labs, an innovative developer of psychedelics-based therapeutics addressing urgent and unmet mental health indications through Real World Evidence (RWE) studies in the UK and across Europe, is pleased to announce the chairs of its Clinical and Scientific Advisory Boards. The company welcomes Professor Jo Neill as the Chair of Albert Labs Clinical Advisory Board and Parminder Singh Chair of its Scientific Advisory Board. We are delighted to have such authority with Jo and Parminder, they bring a wealth of knowledge and expertise in each of their disciplines and we look forward to working with them in driving our Clinical and Scientific Advisory boards said Graeme McFarlane, Chief Commercial Officer of Albert Labs.